Endocrine, Metabolic and Immune Disorders - Drug Targets
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 147 |
| Total Docs. (3 years) | 483 |
| Total Refs. | 9,264 |
| Total Citations (3 years) | 1,112 |
| Citable Docs. (3 years) | 457 |
| Citations / Doc. (2 years) | 2.28 |
| Ref. / Doc. | 63.02 |
| % Female | 47.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Endocrine, Metabolic and Immune Disorders - Drug Targets?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Endocrine, Metabolic and Immune Disorders - Drug Targets has an SJR of 0.552 and is ranked Q3.
What is the SJR and quartile of Endocrine, Metabolic and Immune Disorders - Drug Targets?
Endocrine, Metabolic and Immune Disorders - Drug Targets has an SJR (SCImago Journal Rank) of 0.552 and its best quartile is Q3.
What is the H-index of Endocrine, Metabolic and Immune Disorders - Drug Targets?
The H-index of Endocrine, Metabolic and Immune Disorders - Drug Targets is 69, meaning 69 of its articles have each been cited at least 69 times.
Is Endocrine, Metabolic and Immune Disorders - Drug Targets indexed in Scopus?
Yes. Endocrine, Metabolic and Immune Disorders - Drug Targets is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.